Hvad er CVR-nummeret på FORWARD PHARMA A/S?

FORWARD PHARMA A/S er registreret hos CVR / Virk under CVR 28865880.

Hvad er omsætningen for FORWARD PHARMA A/S?

FORWARD PHARMA A/S rapporterede en omsætning på DKK -9,5M i 2024.

FORWARD PHARMA A/S beskæftiger 2 personer pr. seneste årsrapport.

FORWARD PHARMA A/Ss registrerede adresse er Strandvejen 125.

A/SIn liquidationReklamebeskyttelse

CVR 28865880Strandvejen 125, 2900 HellerupResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2005 · 20 years old2 employees

Aktivt ansatte i selskabet

Name	Role	Member since
Former (7)
PM Peder Møller Andersen Management	Management	2012 – 2017
LF Lars Folke Henrik Nilsson Management	Management	2006 – 2010
CB Claus Bo Søndergaard Svendsen Management	Management	2017 – 2025
JD Joel David Sendek Management	Management	2014 – 2017
MP Morten Priskorn Management	Management	2010 – 2012
RS Rupert Sandbrink Management	Management	2016 – 2017
JD Joel David Sendek Management	Management	2014 – 2014

Ikke-udøvende tilsyn

Name	Role	Member since
Former (12)
DM Duncan Moore Board of Directors	Board of Directors	2016 – 2025
WD Wyle David Solomon Chairman	Chairman	2010 – 2012
GH Grant Hellier Lawrence Board of Directors	Board of Directors	2015 – 2025
JG Johannes Gerardus Joseph van de Winkel Board of Directors	Board of Directors	2014 – 2017
HT Hans Thalsgård Schambye Board of Directors	Board of Directors	2010 – 2012
MK Marianne Kock Board of Directors	Board of Directors	2005 – 2008
CK Christian Karsten Hansen Board of Directors	Board of Directors	2005 – 2010
JM Jakob Mosegaard Larsen Board of Directors	Board of Directors	2015 – 2025
KL Karen Lesley Smith Board of Directors	Board of Directors	2016 – 2017
JK John Kevin Buchi Board of Directors	Board of Directors	2012 – 2016
FS Florian Schønharting Chairman	Chairman	2012 – 2025
TG Torsten Goesch Board of Directors	Board of Directors	2006 – 2024

Pr. seneste årsrapport

Shareholder	Type	Ownership	Votes	Since
Mason Capital Master Fund, L.P.	Individual	5–9.99%	5–9.99%	2024
NORDIC BIOTECH OPPORTUNITY FUND K/S	Company	20–24.99%	20–24.99%	2024
BNY (Nominees) Limited (as nominee of The Bank of New York Mellon)	Individual	5–9.99%	5–9.99%	2024
The Bank of New York Mellon	Individual	20–24.99%	20–24.99%	2014
GEP II, L.P.	Individual	10–14.99%	10–14.99%	2024
NORDIC BIOTECH K/S	Company	20–24.99%	20–24.99%	2024
NB FP INVESTMENT K/S	Company	5–9.99%	5–9.99%	2014
Rosetta Capital I, LP	Individual	15–19.99%	15–19.99%	2014
FORWARD PHARMA A/S	Company	5–9.99%	5–9.99%	2024
Nerine Trust Company Limited	Individual	5–9.99%	5–9.99%	2024

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.